FDAnews Drug Daily Bulletin

TRANSMOLECULAR RELOCATES HEADQUARTERS TO CAMBRIDGE, MA TO ACCOMMODATE NEXT PHASE OF GROWTH

Nov. 17, 2005
A A

TransMolecular, Inc., a biotechnology company focused on cancer drug development, today announced the relocation of its headquarters to Cambridge from Birmingham, Alabama. The company now occupies approximately 4400 square feet of leased office and clinical laboratory space located at The Riverside Technology Center at 840 Memorial Drive in Cambridge.

Genetic Engineering News (http://www.genengnews.com/news/bnitem.aspx?name=1105496XSL_NEWSML_TO_NEWSML_WEB.xml)